ARUP Laboratories

This issue highlights milestones in ARUP’s history, gives a glimpse into the company’s future, and includes a special feature: a video of ARUP founders and current leaders reminiscing and celebrating.

ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs.

Nicola Longo, who with his wife, Marzia Pasquali, is credited with expanding screening for a treatable metabolic disorder, is leaving for UCLA while Pasquali stays at ARUP to continue key projects.